ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025
Specializing in branded and generic pharmaceuticals, this sector player reported a notable insider sale amid a stable transaction pattern.
Source: www.fool.com
Specializing in branded and generic pharmaceuticals, this sector player reported a notable insider sale amid a stable transaction pattern.